(Q51370555)

English

Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.

scientific article published on 20 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study. (English)

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

1 reference

based on heuristic

inferred from title

coronary angiography

1 reference

based on heuristic

inferred from title

author name string

R Doerr

1

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

U Hoffmann

2

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

W Otter

3

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

L Heinemann

4

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

W Hunger-Battefeld

5

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

B Kulzer

6

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

A Klinge

7

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

V Lodwig

8

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

I Amann-Zalan

9

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

D Sturm

10

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

D Tschoepe

11

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

S G Spitzer

12

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

J Stumpf

13

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

T Lohmann

14

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

O Schnell

15

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

publication date

20 July 2011

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

54

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

11

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

2923-2930

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

https://scigraph.springernature.com/pub.10.1007/s00125-011-2253-y

0 references

Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Influence of impaired glucose tolerance on long-term survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Epidemiology of diabetes and diabetes-related complications.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Coronary arteriography. A study of 100 cases with angiographically proved coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

A1C cut points to define various glucose intolerance groups in Asian Indians

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Utility of A1C for diabetes screening in the 1999 2004 NHANES population

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

A1C for screening and diagnosis of type 2 diabetes in routine clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Impaired glucose tolerance, diabetes, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

The Munich Myocardial Infarction Registry: translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2253-Y

21 January 2018

Index for rating diagnostic tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards of medical care in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-011-2253-Y

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21773683

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51370555&oldid=1512787315"